Sai Life Sciences Ltd is a full-service CRO-CDMO with a vision to propel the launch of 25 new medicines by 2025. Founded in 1999 and headquartered in India, the company is a major player in the health care and pharmaceutical industries.
The company's commitment to partnership is evident in its work with innovator pharma and biotech companies to accelerate the discovery, development, and manufacture of complex small molecules for a healthier tomorrow. Their last investment of INR192.57M was made during the Venture Round on 06 March 2019.
This investment was made by HBM Healthcare Investments, reflecting confidence in Sai Life Sciences' vision and capabilities. With a strong focus on innovation and collaboration, the company is on track to achieve its ambitious goal of supporting global innovator partners bring 25 new medicines to life by 2025.